Innovation is the cornerstone of AbbVie’s business as a global biopharmaceutical company. Their focus is on developing medicines that can provide strong clinical performance, measurable patient benefit and economic value, particularly in areas where there is significant need, such as hepatitis C, neuroscience, immunology, oncology, chronic kidney disease and women’s health.
AbbVie combines advanced science, global capabilities and passion to provide innovative therapies that help people manage some of the most serious health conditions.
member
Growing Manitoba’s diverse economy is crucial to building a stronger western Canada. That is why the Government of Canada is investing over $5.9 million in four projects in Manitoba to support future growth opportunities in the life sciences sector.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.